AR095480A1 - Formulación de acetato de abiraterona - Google Patents

Formulación de acetato de abiraterona

Info

Publication number: AR095480A1
Authority: AR; Argentina
Prior art keywords: abiraterone acetate; composition; abiraterone; acetate; milling
Prior art date: 2013-03-15

Application number

ARP140101083A

Other languages

English (en)

Spanish (es)

Original Assignee

Iceutica Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-03-15

Filing date

2014-03-14

Publication date

2015-10-21

2014-03-14 Application filed by Iceutica Inc filed Critical Iceutica Inc

2015-10-21 Publication of AR095480A1 publication Critical patent/AR095480A1/es

Links

229960004103 abiraterone acetate Drugs 0.000 title abstract 6
UVIQSJCZCSLXRZ-UBUQANBQSA-N abiraterone acetate Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CC[C@@H](CC4=CC[C@H]31)OC(=O)C)C=C2C1=CC=CN=C1 UVIQSJCZCSLXRZ-UBUQANBQSA-N 0.000 title abstract 6
239000000203 mixture Substances 0.000 title abstract 5
238000009472 formulation Methods 0.000 title 1
238000000034 method Methods 0.000 abstract 3
239000003963 antioxidant agent Substances 0.000 abstract 2
230000003078 antioxidant effect Effects 0.000 abstract 2
238000009837 dry grinding Methods 0.000 abstract 2
238000003801 milling Methods 0.000 abstract 2
239000002105 nanoparticle Substances 0.000 abstract 2
239000002245 particle Substances 0.000 abstract 2
239000003352 sequestering agent Substances 0.000 abstract 2
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
229960000853 abiraterone Drugs 0.000 abstract 1
GZOSMCIZMLWJML-VJLLXTKPSA-N abiraterone Chemical compound C([C@H]1[C@H]2[C@@H]([C@]3(CC[C@H](O)CC3=CC2)C)CC[C@@]11C)C=C1C1=CC=CN=C1 GZOSMCIZMLWJML-VJLLXTKPSA-N 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000002552 dosage form Substances 0.000 abstract 1
239000011159 matrix material Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Landscapes

Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ARP140101083A 2013-03-15 2014-03-14 Formulación de acetato de abiraterona AR095480A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201361789141P	2013-03-15	2013-03-15

Publications (1)

Publication Number	Publication Date
AR095480A1 true AR095480A1 (es)	2015-10-21

Family

ID=56119111

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP140101083A AR095480A1 (es)	2013-03-15	2014-03-14	Formulación de acetato de abiraterona

Country Status (2)

Country	Link
AR (1)	AR095480A1 (fr)
MA (1)	MA38521B1 (fr)

2014
- 2014-03-14 AR ARP140101083A patent/AR095480A1/es unknown
- 2014-03-17 MA MA38521A patent/MA38521B1/fr unknown

Also Published As

Publication number	Publication date
MA38521A1 (fr)	2017-03-31
MA38521B1 (fr)	2018-12-31

Similar Documents

Publication	Publication Date	Title
CL2015002787A1 (es)	2016-05-13	Formulación de acetato de abiraterona.
CO6470807A2 (es)	2012-06-29	Una formulacion novedosa de indometacina
NZ629438A (en)	2016-10-28	Inhalable pharmaceutical compositions
CO6470806A2 (es)	2012-06-29	Una formulación novedosa de naproxeno
CO6470812A2 (es)	2012-06-29	Método para la producción de polvos de nanopartículas y micropartículas comerciales
CO6470803A2 (es)	2012-06-29	Una formulacion novedosa de meloxicam
MX387363B (es)	2025-03-18	Tratamiento de cáncer con una combinación de radiación, nanopartículas de óxido de cerio y un agente quimioterapéutico.
MX360545B (es)	2018-10-26	Método para mejorar el perfil de disolución de un material biológicamente activo.
PE20141792A1 (es)	2014-12-07	Formas polimorficas de (s)-2-(1-(9h-purin-6-ilamino)propil)-5-fluor-3-fenilquinazolin-4(3h)-ona
MX2014015005A (es)	2015-09-04	Formas cristalinas de un modulador del receptor androgenico.
MX2013008851A (es)	2013-12-16	Composiciones y metodos para el tratamiento de inflamacion cronica y enfermedades inflamatorias.
NI201600093A (es)	2016-07-22	Formulación compuesta para administración oral que comprende ezetimibe y rosuvastatina
HK1212207A1 (en)	2016-06-10	Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
MX2016003711A (es)	2016-05-31	Particulas.
PE20140255A1 (es)	2014-03-11	Tableta dispersable en forma oral
IN2013MU03583A (fr)	2015-07-31
GT201500035A (es)	2017-10-24	Composición farmacéutica oral en forma de microesferas y proceso de elaboración
GB201316021D0 (en)	2013-10-23	Vitamin D composition
MX378141B (es)	2025-03-10	Composición farmacéutica, que comprende partículas de aglutinante de fosfato.
NZ714273A (en)	2019-04-26	Pharmaceutical composition comprising the combination of a biocompatible nanoparticle and a compound of interest, preparation and uses thereof
NZ720328A (en)	2018-02-23	Pyranochromenyl phenol derivative, and pharmaceutical composition for treating metabolic syndrome or inflammatory disease
PE20141048A1 (es)	2014-09-08	Combinacion que comprende umeclidinio y un corticosteroide
AR125850A2 (es)	2023-08-16	Composición farmacéutica tópica, proceso de producción de la composición farmacéutica tópica, uso de la composición farmacéutica tópica y método de tratamiento tópico de psoriasis, dermatitis atópica o eczemas crónicos
MX2017006812A (es)	2018-02-12	Composición farmacéutica, preparación y usos de la misma.
MX367926B (es)	2019-09-12	Composicion farmaceutica para liberacion sostenida de lanreotida.

Legal Events

Date	Code	Title	Description
2020-09-28	FB	Suspension of granting procedure